tetano
Editor, Senior Moderator
J Med Virol
. 2023 Feb 9.
doi: 10.1002/jmv.28565. Online ahead of print.
Concerns on Bebtelovimab (LY-CoV1404) used to neutralize Omicron subvariants
Xuejun Wang[SUP] 1 [/SUP], Yang Yang[SUP] 1 2 [/SUP], Zhifei Song[SUP] 1 [/SUP], Yiming Wang[SUP] 1 3 [/SUP], Peng Yang[SUP] 1 2 [/SUP], Xinyu Li[SUP] 1 [/SUP], Fei Wang[SUP] 1 2 [/SUP], Mingming Wang[SUP] 1 [/SUP], Liting Shao[SUP] 1 [/SUP], Shengqi Wang[SUP] 1 [/SUP]
Affiliations
Abstract
Bebtelovimab (LY-CoV1404) is a monoclonal antibody showing remarkable neutralizing capacity against all SARS-CoV-2 variants of concern (VOCs) as of June 2022, including the Omicron variant and its subvariants This article is protected by copyright. All rights reserved.
Keywords: Antibody susceptibility; Coronavirus; Evolution; SARS coronavirus; Virus classification.
. 2023 Feb 9.
doi: 10.1002/jmv.28565. Online ahead of print.
Concerns on Bebtelovimab (LY-CoV1404) used to neutralize Omicron subvariants
Xuejun Wang[SUP] 1 [/SUP], Yang Yang[SUP] 1 2 [/SUP], Zhifei Song[SUP] 1 [/SUP], Yiming Wang[SUP] 1 3 [/SUP], Peng Yang[SUP] 1 2 [/SUP], Xinyu Li[SUP] 1 [/SUP], Fei Wang[SUP] 1 2 [/SUP], Mingming Wang[SUP] 1 [/SUP], Liting Shao[SUP] 1 [/SUP], Shengqi Wang[SUP] 1 [/SUP]
Affiliations
- PMID: 36756927
- DOI: 10.1002/jmv.28565
Abstract
Bebtelovimab (LY-CoV1404) is a monoclonal antibody showing remarkable neutralizing capacity against all SARS-CoV-2 variants of concern (VOCs) as of June 2022, including the Omicron variant and its subvariants This article is protected by copyright. All rights reserved.
Keywords: Antibody susceptibility; Coronavirus; Evolution; SARS coronavirus; Virus classification.